Spectrum Pharmaceuticals was founded in 2002 and is headquartered in Henderson, US

Spectrum Pharmaceuticals has an office in Henderson

Henderson, US (HQ)

240 11500 S Eastern Ave

Spectrum Pharmaceuticals's revenue was reported to be $29.1 m in Q1, 2017

USD

## Revenue (Q1, 2017) | 29.1 m |

## Gross profit (Q1, 2017) | 21 m |

## Gross profit margin (Q1, 2017), % | 72% |

## Net income (Q1, 2017) | (23 m) |

## EBIT (Q1, 2017) | (21.3 m) |

## Market capitalization (17-Aug-2017) | 742.5 m |

## Cash (31-Mar-2017) | 137.2 m |

Spectrum Pharmaceuticals's current market capitalization is $742.5 m.

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 143.5 m | 186.5 m | 136.9 m | 146.4 m |

## Revenue growth, % | 30% | (27%) | 7% | |

## Cost of goods sold | 28.6 m | 27 m | 27.7 m | 28 m |

## Gross profit | 114.9 m | 159.5 m | 109.2 m | 118.5 m |

## Gross profit Margin, % | 80% | 86% | 80% | 81% |

## Operating expense total | 194.6 m | 218.4 m | 203.3 m | 208.1 m |

## EBIT | (38.8 m) | (31.6 m) | (40.7 m) | (61.6 m) |

## EBIT margin, % | (27%) | (17%) | (30%) | (42%) |

## Interest expense | (2.2 m) | (8.6 m) | (9.1 m) | (9.4 m) |

## Interest income | (2.2 m) | (8.6 m) | (9.1 m) | (9.4 m) |

## Pre tax profit | (36.6 m) | (43.5 m) | (50.4 m) | (70.8 m) |

## Income tax expense | (25.5 m) | (2.2 m) | (406 k) | |

## Net Income | (62.1 m) | (45.7 m) | (50.8 m) | (68.5 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 46.9 m | 48 m | 38.6 m | 45 m | 28.6 m | 43.9 m | 33.9 m | 33.4 m | 29.1 m |

## Cost of goods sold | 6.2 m | 6.5 m | 7.1 m | 6 m | 8.4 m | 5.6 m | 5.6 m | 7.5 m | 8.1 m |

## Gross profit | 40.7 m | 41.5 m | 31.5 m | 39 m | 20.2 m | 38.3 m | 28.3 m | 25.9 m | 21 m |

## Gross profit Margin, % | 87% | 86% | 82% | 87% | 70% | 87% | 83% | 78% | 72% |

## R&D expense | 11.3 m | 14.4 m | 15.9 m | 9.6 m | 9.9 m | 15.5 m | 14.3 m | 13.3 m | 14.7 m |

## General and administrative expense | 25.4 m | 24.1 m | 23.3 m | 22.6 m | 19.4 m | 22 m | 27.6 m | 19.5 m | 18.6 m |

## Operating expense total | 36.7 m | 38.5 m | 39.2 m | 32.1 m | 29.3 m | 37.4 m | 41.9 m | 32.8 m | 33.3 m |

## EBIT | (1.4 m) | (4.1 m) | (21.7 m) | (34 k) | (16.1 m) | (6.3 m) | (22.1 m) | (16 m) | (21.3 m) |

## EBIT margin, % | (3%) | (9%) | (56%) | (0%) | (56%) | (14%) | (65%) | (48%) | (73%) |

## Interest expense | (2 m) | (2.4 m) | (2.2 m) | (2.3 m) | (2.3 m) | (2.3 m) | (2.4 m) | (2.4 m) | (2.1 m) |

## Pre tax profit | (4.9 m) | (8.1 m) | (25.4 m) | (2.4 m) | (18.8 m) | (9.4 m) | (24.4 m) | (17.9 m) | (23.2 m) |

## Income tax expense | 1.3 m | (3.5 m) | (138 k) | 201 k | |||||

## Net Income | (3.6 m) | (11.5 m) | (25.6 m) | (2.3 m) | (18.7 m) | (9.3 m) | (24.3 m) | (17.5 m) | (23 m) |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 156.3 m | 129.9 m | 139.7 m | 158.2 m |

## Accounts Receivable | 7.5 m | 5.5 m | 12.6 m | 5.8 m |

## Inventories | 13.5 m | 9.2 m | 4.2 m | 8.7 m |

## Current Assets | 235.2 m | 222.5 m | 191.3 m | 216.7 m |

## PP&E | 1.5 m | 1.4 m | 918 k | 449 k |

## Goodwill | 18.5 m | 18.2 m | 18 m | 17.9 m |

## Total Assets | 499.2 m | 490 m | 421.2 m | 428.8 m |

## Accounts Payable | 61.1 k | |||

## Current Liabilities | 90 m | 109.4 m | 76.3 m | 65.5 m |

## Total Liabilities | 192.7 m | |||

## Preferred Stock | 123 k | |||

## Additional Paid-in Capital | 518.1 m | 538.6 m | 552.1 m | 640.2 m |

## Retained Earnings | (237.6 m) | (283.3 m) | (334.1 m) | (402.6 m) |

## Total Equity | 281.6 m | 254.6 m | 212.9 m | 236 m |

## Financial Leverage | 1.8 x | 1.9 x | 2 x | 1.8 x |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Cash | 132.4 m | 144.2 m | 123.4 m | 142.3 m | 136.5 m | 132.3 m | 155.8 m | 171.6 m | 137.2 m |

## Accounts Receivable | 11.8 m | 9.3 m | 7.9 m | 8.2 m | 13.5 m | 15.2 m | 7 m | 7.1 m | 5.9 m |

## Inventories | 10.9 m | 9.9 m | 9.1 m | 8.8 m | 7.1 m | 3.2 m | 6.4 m | 7.3 m | 10.4 m |

## Current Assets | 220.1 m | 231.6 m | 216 m | 207.2 m | 209.5 m | 172.5 m | 206.7 m | 231.4 m | 197 m |

## PP&E | 1.4 m | 1.4 m | 1.3 m | 1.3 m | 1.1 m | 810 k | 643 k | 538 k | 493 k |

## Goodwill | 18.5 m | 18.3 m | 17.9 m | 18 m | 18 m | 18 m | 18 m | 18 m | 17.9 m |

## Total Assets | 474.9 m | 509.7 m | 468.6 m | 454.3 m | 447.7 m | 401.4 m | 429.2 m | 449.4 m | 403.5 m |

## Current Liabilities | 77.5 m | 112.9 m | 109.8 m | 90.5 m | 102.3 m | 59.5 m | 58.3 m | 62.3 m | 57.2 m |

## Additional Paid-in Capital | 532.6 m | 535.6 m | 541.2 m | 545.4 m | 548.2 m | 555.1 m | 606.2 m | 638 m | 642.5 m |

## Retained Earnings | (268.8 m) | (280.4 m) | (308.9 m) | (311.2 m) | (330 m) | (343.4 m) | (367.7 m) | (385.2 m) | (425.6 m) |

## Total Equity | 265.7 m | 256.6 m | 234.1 m | 214.7 m | 208.3 m | 235.9 m | 250.8 m | 217.4 m | |

## Financial Leverage | 1.8 x | 2 x | 1.9 x | 2.1 x | 1.9 x | 1.8 x | 1.8 x | 1.9 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | (62.1 m) | (45.7 m) | (50.8 m) | (68.5 m) |

## Depreciation and Amortization | 22.1 m | 25.4 m | 31.9 m | 26.5 m |

## Accounts Receivable | 42.6 m | (22 m) | 40.2 m | (9.5 m) |

## Inventories | 1.6 m | 4.3 m | 1.9 m | (5.8 m) |

## Cash From Operating Activities | (2.1 m) | (3.6 m) | 6.7 m | (40.5 m) |

## Purchases of PP&E | (161 k) | (934 k) | (223 k) | (78 k) |

## Cash From Investing Activities | (14.3 m) | (21.8 m) | 2.8 m | (679 k) |

## Cash From Financing Activities | 35.3 m | 812 k | 1.5 m | 59.6 m |

## Interest Paid | 1.2 m | 3.2 m | 3.3 m | 3.3 m |

## Income Taxes Paid | 329 k | 335 k | 11 k |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (3.6 m) | (11.5 m) | (25.6 m) | (2.3 m) | (18.7 m) | (9.3 m) | (24.3 m) | (17.5 m) | (23 m) |

## Accounts Receivable | 11.8 m | 9.3 m | 7.9 m | 8.2 m | 13.5 m | 15.2 m | 7 m | 7.1 m | 5.9 m |

## Inventories | 10.9 m | 9.9 m | 9.1 m | 8.8 m | 7.1 m | 3.2 m | 6.4 m | 7.3 m | 10.4 m |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 132.6 k |

## Financial Leverage | 1.9 x |